Alana D Carpenter
Overview
Explore the profile of Alana D Carpenter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
66
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Carpenter A, Fatanmi O, Wise S, Petrus S, Tyburski J, Cheema A, et al.
Metabolites
. 2024 Jan;
14(1).
PMID: 38248821
Ionizing radiation exposure is known to induce molecular and cellular injury, inflicting a cascade of potentially catastrophic events leading to tissue and organ damage. Metabolomic analysis allows for the identification...
12.
Garg T, Garg S, Miousse I, Wise S, Carpenter A, Fatanmi O, et al.
Radiat Res
. 2023 Dec;
201(1):55-70.
PMID: 38059553
Currently, no radioprotectors have been approved to mitigate hematopoietic injury after exposure to ionizing radiation. Acute ionizing radiation results in damage to both hematopoietic and immune system cells. Pre-exposure prophylactic...
13.
Singh V, Fatanmi O, Wise S, Carpenter A, Janocha B, Seed T
Radiat Prot Dosimetry
. 2023 Sep;
199(14):1526-1532.
PMID: 37721071
Threats of radiological or nuclear disasters are of serious concern and a top priority for government agencies involved in domestic security and public health preparedness. There is a need for...
14.
Vellichirammal N, Sethi S, Avuthu N, Wise S, Carpenter A, Fatanmi O, et al.
BMC Genomics
. 2023 May;
24(1):274.
PMID: 37217865
The risk of exposure of the general public or military personnel to high levels of ionizing radiation from nuclear weapons or radiological accidents is a dire national security matter. The...
15.
Singh V, Carpenter A, Janocha B, Petrus S, Fatanmi O, Wise S, et al.
Expert Opin Drug Discov
. 2023 Apr;
18(7):797-814.
PMID: 37073409
Background: Animal models are vital for the development of radiation medical countermeasures for the prophylaxis or treatment of acute radiation syndrome and for the delayed effects of acute radiation exposure....
16.
Carpenter A, Li Y, Janocha B, Wise S, Fatanmi O, Maniar M, et al.
J Proteome Res
. 2023 Mar;
22(4):1116-1126.
PMID: 36977373
There are currently four radiation medical countermeasures that have been approved by the United States Food and Drug Administration to mitigate hematopoietic acute radiation syndrome, all of which are repurposed...
17.
Singh V, Serebrenik A, Fatanmi O, Wise S, Carpenter A, Janocha B, et al.
Radiat Res
. 2023 Jan;
199(3):294-300.
PMID: 36689635
Acute exposure to high dose radiation can cause acute radiation syndrome (ARS), a potentially life-threatening illness. Individuals that survive ARS are at risk of developing the delayed effects of acute...
18.
Garg T, Garg S, Miousse I, Wise S, Carpenter A, Fatanmi O, et al.
Int J Mol Sci
. 2022 Dec;
23(24).
PMID: 36555814
Radiation exposure causes acute damage to hematopoietic and immune cells. To date, there are no radioprotectors available to mitigate hematopoietic injury after radiation exposure. Gamma-tocotrienol (GT3) has demonstrated promising radioprotective...
19.
Singh V, Fatanmi O, Wise S, Carpenter A, Olsen C
Radiat Res
. 2022 Oct;
198(6):599-614.
PMID: 36279323
Well-characterized and validated animal models are required for the development of medical countermeasures (MCMs) for acute radiation syndrome to mitigate injury due to high doses of total- or partial-body irradiation....
20.
Vellichirammal N, Sethi S, Pandey S, Singh J, Wise S, Carpenter A, et al.
Mol Ther Nucleic Acids
. 2022 Sep;
29:584-598.
PMID: 36090752
The focus of radiation biodosimetry has changed recently, and a paradigm shift for using molecular technologies of omic platforms in addition to cytogenetic techniques has been observed. In our study,...